The R47H variant of TREM2 shows a rare mutation within the ligand-binding region of the receptor, which abrogates the response to PS and other putative ligands [20, 24] and increases the risk of neurodegenerative pathologies as Alzheimer disease [12, 46]. The gene discussed is TREM2; the disease is early-onset autosomal dominant Alzheimer disease.